Dalia Mahdy

Papers

Total Citations

H-Index

About

Dalia Mahdy is a pioneering researcher at the intersection of robotics and biomedical engineering, whose work is reshaping drug development and tissue engineering. Her primary research areas include robotic-enabled biological automation, 3D tissue production, and the development of animal-free testing platforms. Mahdy’s most notable contribution is her work on ReBiA—Robotic Enabled Biological Automation, which introduced a groundbreaking system for producing 3D epithelial tissue. This innovation directly addresses the global shift away from animal testing, as highlighted by the FDA’s recent decision to eliminate mandatory animal testing for drug approval and the European Parliament’s push for faster transitions to alternative methods. Her 2024 paper on this topic has already garnered 13 citations, signaling its rapid impact on the field. By integrating robotics with tissue engineering, Mahdy is enabling scalable, reproducible, and ethical production of human-relevant tissues for pharmaceutical testing. Her work not only aligns with public demand for animal-free research but also accelerates the development of safer, more effective drugs. For students and researchers, Mahdy exemplifies how interdisciplinary approaches can solve critical challenges in biomedical science and regulatory policy.